Circulating levels of ATP is a biomarker of HIV cognitive impairment

Background: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of...

Full description

Bibliographic Details
Main Authors: Stephani Velasquez, Lisa Prevedel, Silvana Valdebenito, Anna Maria Gorska, Mikhail Golovko, Nabab Khan, Jonathan Geiger, Eliseo A. Eugenin
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396419306929
_version_ 1818576966460112896
author Stephani Velasquez
Lisa Prevedel
Silvana Valdebenito
Anna Maria Gorska
Mikhail Golovko
Nabab Khan
Jonathan Geiger
Eliseo A. Eugenin
author_facet Stephani Velasquez
Lisa Prevedel
Silvana Valdebenito
Anna Maria Gorska
Mikhail Golovko
Nabab Khan
Jonathan Geiger
Eliseo A. Eugenin
author_sort Stephani Velasquez
collection DOAJ
description Background: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed. Methods: We analyze the opening of one of the larger channels expressed by humans, pannexin-1 (Panx-1) channels, in the uninfected and HIV infected population (n = 175). We determined channel opening and secretion of intracellular second messengers released through the channel such as PGE2 and ATP. Also, we correlated the opening of Panx-1 channels with the circulating levels of PGE2 and ATP as well as cogntive status of the individuals analyzed. Findings: Here, we demonstrate that Panx-1 channels on fresh PBMCs obtained from uninfected individuals are closed and no significant amounts of PGE2 and ATP are detected in the circulation. In contrast, in all HIV-infected individuals analyzed, even the ones under effective ART, a spontaneous opening of Panx-1 channels and increased circulating levels of PGE2 and ATP were detected. Circulating levels of ATP were correlated with cognitive decline in the HIV-infected population supporting that ATP is a biomarker of cognitive disease in the HIV-infected population. Interpretation: We propose that circulating levels of ATP could predict CNS compromise and lead to the breakthroughs necessary to detect and prevent brain compromise in the HIV-infected population. Keywords: Anti-retroviral/dementia/HIV-1 reservoirs/NeuroHIV/Pannexin
first_indexed 2024-12-16T06:22:25Z
format Article
id doaj.art-d81ec7d2555446a8b2025cd167bde196
institution Directory Open Access Journal
issn 2352-3964
language English
last_indexed 2024-12-16T06:22:25Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series EBioMedicine
spelling doaj.art-d81ec7d2555446a8b2025cd167bde1962022-12-21T22:41:05ZengElsevierEBioMedicine2352-39642020-01-0151Circulating levels of ATP is a biomarker of HIV cognitive impairmentStephani Velasquez0Lisa Prevedel1Silvana Valdebenito2Anna Maria Gorska3Mikhail Golovko4Nabab Khan5Jonathan Geiger6Eliseo A. Eugenin7Department of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Research Building 17, Fifth Floor, 105 11th Street, Galveston, Texas, 77555, USADepartment of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Research Building 17, Fifth Floor, 105 11th Street, Galveston, Texas, 77555, USADepartment of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Research Building 17, Fifth Floor, 105 11th Street, Galveston, Texas, 77555, USADepartment of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Research Building 17, Fifth Floor, 105 11th Street, Galveston, Texas, 77555, USADepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USADepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USADepartment of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, USADepartment of Neuroscience, Cell Biology, and Anatomy, University of Texas Medical Branch (UTMB), Research Building 17, Fifth Floor, 105 11th Street, Galveston, Texas, 77555, USA; Corresponding author.Background: In developed countries, Human Immunodeficiency Virus type-1 (HIV-1) infection has become a chronic disease despite the positive effects of anti-retroviral therapies (ART), but still at least half of the HIV infected population shown signs of cognitive impairment. Therefore, biomarkers of HIV cognitive decline are urgently needed. Methods: We analyze the opening of one of the larger channels expressed by humans, pannexin-1 (Panx-1) channels, in the uninfected and HIV infected population (n = 175). We determined channel opening and secretion of intracellular second messengers released through the channel such as PGE2 and ATP. Also, we correlated the opening of Panx-1 channels with the circulating levels of PGE2 and ATP as well as cogntive status of the individuals analyzed. Findings: Here, we demonstrate that Panx-1 channels on fresh PBMCs obtained from uninfected individuals are closed and no significant amounts of PGE2 and ATP are detected in the circulation. In contrast, in all HIV-infected individuals analyzed, even the ones under effective ART, a spontaneous opening of Panx-1 channels and increased circulating levels of PGE2 and ATP were detected. Circulating levels of ATP were correlated with cognitive decline in the HIV-infected population supporting that ATP is a biomarker of cognitive disease in the HIV-infected population. Interpretation: We propose that circulating levels of ATP could predict CNS compromise and lead to the breakthroughs necessary to detect and prevent brain compromise in the HIV-infected population. Keywords: Anti-retroviral/dementia/HIV-1 reservoirs/NeuroHIV/Pannexinhttp://www.sciencedirect.com/science/article/pii/S2352396419306929
spellingShingle Stephani Velasquez
Lisa Prevedel
Silvana Valdebenito
Anna Maria Gorska
Mikhail Golovko
Nabab Khan
Jonathan Geiger
Eliseo A. Eugenin
Circulating levels of ATP is a biomarker of HIV cognitive impairment
EBioMedicine
title Circulating levels of ATP is a biomarker of HIV cognitive impairment
title_full Circulating levels of ATP is a biomarker of HIV cognitive impairment
title_fullStr Circulating levels of ATP is a biomarker of HIV cognitive impairment
title_full_unstemmed Circulating levels of ATP is a biomarker of HIV cognitive impairment
title_short Circulating levels of ATP is a biomarker of HIV cognitive impairment
title_sort circulating levels of atp is a biomarker of hiv cognitive impairment
url http://www.sciencedirect.com/science/article/pii/S2352396419306929
work_keys_str_mv AT stephanivelasquez circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT lisaprevedel circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT silvanavaldebenito circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT annamariagorska circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT mikhailgolovko circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT nababkhan circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT jonathangeiger circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment
AT eliseoaeugenin circulatinglevelsofatpisabiomarkerofhivcognitiveimpairment